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Abstract
Background: The aims of this study were to propose a Spanish Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) short form based on previously shortened versions and to study its validity, reliability,
and responsiveness for patients with hip osteoarthritis undergoing total hip replacement (THR).
Methods: Prospective observational study of two independent cohorts (788 and 445 patients, respectively).
Patients completed the WOMAC and the Short Form (SF)-36 questionnaires before THR and 6 months afterward.
Patients received the questionnaires by mailing, and two reminder letters were sent to patients who had not
replied the questionnaire. Based on two studies from the literature, we selected the two shortened domains, the
pain domain composed of three items and the function domain composed of eight items. Thus, we proposed an
11-items WOMAC short form. A complete validation process was performed, including confirmatory factor analysis
(CFA) and Rasch analysis, and a study of reliability, responsiveness, and agreement measured by the Bland-Altman
approach.
Results: The mean age was about 69 years and about 49% were women. CFA analyses confirmed the two-factor
model. The pain and function domains fit the Rasch model. Stability was supported with similar results in both
cohorts. Cronbach’s alpha coefficients were high, 0.74 and 0.88. The highest correlations in convergent validity
were found with the bodily pain and physical function SF-36 domains. Significant differences were found
according to different pain and function severity scales, supporting known-groups validity. Responsiveness
parameters showed large changes (effect sizes, 2.11 and 2.29). Agreement between the WOMAC long and short
forms was adequate.
Conclusions: Since short questionnaires result in improved patient compliance and response rates, it is very useful
to have a shortened WOMAC version with the same good psychometric properties as the original version. The
Spanish WOMAC short form is valid, reliable, and responsive for patients undergoing THR, and most importantly,
the first WOMAC short version proposed in Spanish. Because of its simplicity and ease of application, the short
form is a good alternative to the original WOMAC questionnaire and it would further enhance its acceptability and
usefulness in clinical research, clinical trials, and in routine practice within the orthopaedic community.
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Background
The disease-specific questionnaire, Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC),
is the most widely used instrument to evaluate sympto-
matology and function in patients with hip or knee
osteoarthritis (OA) [1-5]. The measure was developed to
evaluate clinically important, patient-relevant changes in
health status resulting from treatment interventions [6].
The WOMAC, which is self-administered and covers
three dimensions: pain (5 items), stiffness (2 items), and
physical function (17 items), is reliable, valid, and sensi-
tive to changes in the health status of patients with hip
or knee OA [1,7-10].
A major uses of health measurement scales is to
detect health status changes over time, and a priority
may be efficiency, i.e., responses achieved using the
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sion would further enhance its applicability in epidemio-
logic studies, clinical trials, and daily clinical practice
[13], since short questionnaires result in improved
patient compliance and response rates and are thought
to improve the quality of the response [14,15]. Tradi-
tionally, one of the major disadvantages of self-adminis-
tered questionnaires has been the low response rate,
which greatly affects the study validity [15,16], but it has
been shown that shorter version of the questionnaires
w o u l ds i g n i f i c a n t l yi n c r e a s et h er e s p o n s er a t e[ 1 5 ] .I n
addition, several studies have reported that the
WOMAC function scale is redundant and suggested
that the scale should be shortened by omitting the repe-
titious items [17,18]. Therefore, it would be very useful
to have a shortened WOMAC version in Spanish, which
retains the same good psychometric properties of the
original version.
The WOMAC questionnaire has been shortened
recently [11,19-21]. Some have been shortened using
statistical approaches [19,20], and others by considering
the perspective of patients and rheumatologists [11,21].
The stiffness domain of the WOMAC is largely redun-
dant and is often excluded from the questionnaire [21].
Therefore, some authors have centred their studies on
shortening the function domain [11,21], while others
have shortened the pain and function domains [19,20],
but these shortened domains have not been validated as
a whole shortened WOMAC version, checking the exis-
tence of two underlying domains. Since the shortened
scale is essentially a component of the fully shortened
version, the subjacent structure of the reduced version
should be analyzed.
The goal of the current study was to propose a shor-
tened Spanish WOMAC version based on previously
shortened versions and to evaluate the validity, reliabil-
ity, and responsiveness of this shortened questionnaire
for patients with hip OA, combining classical and mod-
ern statistical techniques, such as Rasch analysis.
Methods
Study population
The current study included data from two prospective
cohorts recruited independently from various public
teaching hospitals. Consecutive patients who underwent
total hip replacement (THR) between March 1999 and
March 2000, and between September 2003 and September
2004, were eligible for the study and included in cohort 1
and 2, respectively. In both cohorts, patients with main
diagnosis different to hip or knee osteoarthritis (OA), or
with a malignant pathology or other organic or psychiatric
condition that prevented participation, or with failure to
undergo surgical intervention were excluded. Each hospi-
tal’s ethics review board approved the study.
Measurements
The data collection and methodology for both cohorts
were the same. All patients on the waiting list for a
THR were mailed to their home address a letter that
described the study and requested voluntary participa-
tion. The WOMAC [1], short Form (SF)-36 [22] ques-
tionnaires, and additional questions regarding the level
of pain and function, which we will refer to as the cate-
gorical scales, were included in the mailing. The struc-
ture of those variables has been described previously
[23], and they classified patients as having minor, mod-
erate, and severe pain or function. Therefore, patients
completed the questionnaires at home, and they
returned them by mail. A reminder letter was sent to
patients who had not replied after 15 days. The patients
who still had not responded after another 15 days
received the questionnaire again and were contacted by
telephone to ask them about the reasons of their non
response. Six months after the intervention, patients
received the same questionnaires and the follow up for
those not responding was as described previously. Socio-
demographic and clinical data also were collected.
The SF-36 is a generic questionnaire on health-related
quality of life [22] that has 36 items and covers eight
domains (physical function, physical role, bodily pain,
general health, vitality, social function, emotional role,
and mental health) and two summary scales on physical
and mental health. The scores for the SF-36 domains
range from 0 to 100, with higher scores indicating better
health status. The SF-36 has been translated into Span-
ish and validated in Spanish populations [24].
The WOMAC is a health status instrument specific
for patients with hip or knee OA [1]. It has a multidi-
mensional scale comprising 24 items grouped into three
dimensions: pain (5 items), stiffness (2 items), and physi-
cal function (17 items). We used the Likert version of
the WOMAC with five response levels for each item,
representing different degrees of intensity that were
scored from 0 (none) to 4 (extreme). The WOMAC has
been translated into Spanish and validated in Spain
[8-10].
After a thorough review of the literature and existing
shortened WOMAC versions, we derived the WOMAC
s h o r tf o r m( W O M A C - S F )f r o mt h eo r i g i n a lW O M A C
version to evaluate pain and function in patients with
hip OA. The WOMAC pain short form was selected
from a previously shortened version using Rasch analysis
[19], which included items 1, 2, and 4 of the long form.
T h ef u n c t i o ns h o r tf o r mi n c l u d e di t e m s1 ,2 ,3 ,6 ,7 ,8 ,
9, and 15 of the long form, selected from a previous
study based on patients’ and experts’ opinions [11].
Some psychometric properties of the function short
form have been investigated previously [25]. Therefore,
t h eW O M A C - S Ft h a tw ep r o p o s e dh a s1 1i t e m s
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tion (8 items). The final scores for the long and short
WOMAC versions were determined by adding the
aggregate scores for pain and function separately, and
standardizing them to a range of values from 0 to 100,
with 0 representing the best health status possible and
100 the worst.
Statistical analysis
The unit of the study was the patient. In cases in which
a patient underwent two interventions during the
recruitment period, we selected the first intervention
performed.
To describe the samples, we used means and standard
deviations (SDs), frequencies, and percentages. We com-
pared sociodemographic and clinical data and WOMAC
domains at baseline between the cohorts. Chi-square or
Fisher’s exact tests were performed to compare categori-
cal variables, and the t-test or the Wilcoxon nonpara-
metric test was used to compare continuous variables.
Cohort 1 was used to study all the psychometric prop-
erties performed to validate the Spanish 11-item
WOMAC-SF. With the aim of studying the stability of
items performance across different samples to give more
evidence of validity, analyses concerning the construct
validity were replicated in cohort 2.
Construct validity
We studied the construct validity by means of confirma-
tory factor analysis (CFA) to investigate the hypothesis
that the 11 items on the questionnaire addressed two
factors, pain and function. Different fit indexes were
evaluated [26-29]: the root mean square error of approx-
imation (RMSEA), for which a value below 0.08 was
considered acceptable; and the non-normed fit index
(NNFI) and comparative fit index (CFI), both of which
had to exceed 0.90 to be satisfactory. We also examined
factor loadings, and those 0.40 or higher were consid-
ered acceptable. We performed the CFA in both cohorts
to study the stability of the subjacent structure of the
questionnaire.
We applied the Rasch method to the WOMAC pain
and function short forms separately to ensure that the
scales were unidimensional [17,30], a fundamental
requirement of construct validity [31]. We assessed uni-
dimensionality by means of infit and outfit statistics,
with values between 0.7 and 1.3 indicating a good fit
[32], and through a principal components analysis
(PCA) of the residuals extracted from the Rasch model
[19,20]. Unidimensionality was considered violated if, in
addition to the first factors, other factors had eigenva-
lues exceeding 3 [33]. We evaluated the ability of the
WOMAC-SF to define a distinct hierarchy of items
along the measured variable by means of an item
separation index [30]. A value of 2.0 or greater for this
statistic is comparable to reliability of 0.80 and is accep-
table. To detect the presence of differential item func-
tioning (DIF), which occurs when different groups
within the sample respond in a different manner to an
individual item [34], we compared the different levels of
the trait by gender. A Welch t statistically significant at
P< 0.05, and a difference in difficulty of at least 0.5 logit
was considered as noticeable DIF [33]. We performed
Rasch analyses in both cohorts to study the stability of
the item logits and item order across the different
samples.
Reliability
We assessed reliability using Cronbach’s alpha coeffi-
cient [35]. A coefficient over 0.70 was considered accep-
table [36].
Convergent and discriminant validity
We assessed convergent and discriminant validity by
analysing the relationship between the WOMAC-SF
domains and the SF-36 domains with the Spearman cor-
relation coefficient. We established that correlations
between the WOMAC-SF domains and the other mea-
sures must be lower than the internal consistency of the
WOMAC-SF scales [37]. We also hypothesized that the
correlation between the WOMAC short pain scale and
t h eb o d i l yp a i nd o m a i no ft h eS F - 3 6a n db e t w e e nt h e
WOMAC short function scale and the physical function
SF-36 domain would be higher than with the other
domains.
Known-groups validity
We examined known-groups validation by comparing
the WOMAC pain and function short scales among the
different groups according to pain and function catego-
rical scales [23]. We hypothesized that the more severe
the patient’s pain or function level, the higher their
WOMAC pain and function short scores would be.
Analysis of variance using the Scheffe test for multiple
comparisons or the non-parametric Kruskal-Wallis test
was performed for the analysis.
Responsiveness
We compared principal characteristics between patients
who responded to the follow-up and those who did not.
Means and SDs were calculated for the WOMAC-SF
scales at baseline and 6 months after surgery. We used
a paired t-test for the comparison before and after the
intervention. Ceiling and floor effects at baseline and 6
months after surgery were examined to evaluate the dis-
criminatory ability of the scales.
To measure the responsiveness of the WOMAC-SF,
we used the standardized effect size (SES), defined as
the mean change score divided by the SD of the baseline
scores, and standardized response mean (SRM), defined
as the mean change score divided by the SD of the
change scores [38]. Cohen’s benchmarks were used to
classify the magnitude of the effect sizes [39].
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We evaluated the correlations between the pain and
function long and short scales at baseline, 6 months
after intervention, and for changes in scores by Spear-
man’s correlation coefficient. Agreement between the
WOMAC long and short scales was examined by the
Bland-Altman approach [40], which is useful for search-
ing for any systematic bias, assessing random error, and
revealing whether the difference between the scores
depends on the level of the scores [25].
All statistical analyses were performed with SAS for
Windows statistical software, version 9.1 (SAS Institute,
Inc., Cary, NC), except the Rasch analysis for which we
used Winsteps version 3.69.1.4 software (John M.
Linacre, Chicago).
Results
During the recruitment period, we included 788 and 445
patients in the first and second cohorts respectively, who
underwent a THR, fulfilled selection criteria, and accepted
to participate. Of these, 590 (74.87%) and 339 (76.18%),
respectively, completed the questionnaires 6 months after
the intervention. No differences were observed between
both cohorts, except for the function categorical scale and
WOMAC scales, with poorer results in cohort 2 (Table 1).
Construct validity
The results of the CFA for the hypothesized model of
two latent factors, pain and function, provided satisfac-
tory fit indices in both cohorts (Table 2). The RMSEA
values were less than 0.08, and CFI and NNFI values
were all exceeding the benchmark of 0.90. All factor
loadings were significant (P< 0.001) (range, 0.53 - 0.84)
and similar in both cohorts, which supported the stabi-
lity of the subjacent structure of the short questionnaire
across the different samples.
Regarding the results of the Rasch analyses for the
WOMAC pain and function short scales (Table 3), items
were separated by 0.10 or more logit unit in both cohorts.
Items were equally ranked based on their level of diffi-
culty (δ) in both cohorts, which supported the stability of
items across the different samples. Unidimensionality
was supported with infit and outfit statistics ranging
between 0.7 and 1.3, except the item “pain on sitting or
lying” relative to pain scale in the first cohort (infit =
1.33, outfit = 1.32) and the item “putting on socks” rela-
tive to function scale in cohort 2 (infit = 1.32). Further-
more, the PCA of the residuals did not yield additional
factors with eigenvalues exceeding 3, since the second
eigenvalue was 1.2 for the pain scale and 1.4 for the func-
tion scale in both cohorts, implying that the unidimen-
sionality was not violated. In both cohorts, the person
and item separation indexes exceeded 2, indicating relia-
b i l i t yo v e r0 . 8 0 .T h ep r e s e n c eo fD I Fb yg e n d e rw a sn o t
detected, given that in no case, the difference in the level
of severity according to gender was statistically significant
neither it was higher than 0.5 logits.
Reliability
Cronbach’s alpha coefficient was 0.74 for the WOMAC
pain short scale, and 0.88 for the function short scale,
which was superior to the minimum value of 0.70.
Table 1 Sociodemographic, clinical, and WOMAC
preintervention descriptive statistics of samples
Parameter Cohort 1
(n = 788)
Cohort 2
(n = 445)
P
value
Age, mean (SD) 69.14
(8.91)
68.42
(9.81)
0.2039
Gender, women 381
(48.35)
221
(49.66)
0.6579
Body mass index 0.2707
< 25 146
(19.36)
99 (23.19)
25-30 358
(47.48)
198
(46.37)
≥ 30 250
(33.16)
130
(30.44)
Surgical risk 0.5047
ASA I-III 773
(98.10)
434
(97.53)
ASA IV 15 (1.90) 11 (2.47)
Charlson comorbidity index 0.9341
0 463
(58.76)
266
(59.78)
1 218
(27.66)
121
(27.19)
>1 107
(13.58)
58 (13.03)
Pain categorical scale 0.4593
Minor 32 (4.09) 12 (2.72)
Moderate 171
(21.87)
96 (21.77)
Severe 579
(74.04)
333
(75.51)
Functional limitation categorical scale 0.0076
Minor 79 (10.04) 36 (8.13)
Moderate 422
(53.62)
206
(46.50)
Severe 286
(36.34)
201
(45.37)
WOMAC preintervention domains,
mean (SD)
Pain 54.27
(18.63)
58.16
(19.47)
0.0006
Function 65.19
(16.61)
68.44
(16.85)
0.0011
Data are expressed as frequency (percentage) unless otherwise stated.
Percentages exclude patients with missing data.
The scores for the WOMAC domains range from 0 to 100, with higher scores
indicating worse health status.
SD = Standard deviation; ASA = American Society of Anesthesiologists.
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The correlation coefficients between the WOMAC
pain and function short scales and the SF-36 domains
were all lower than the Cronbach’sa l p h ao ft h e
WOMAC-SF scales (Table 4). As hypothesized, the
highest correlation coefficient of the WOMAC pain
and function short scales were found with the SF-36
bodily pain and physical functioning domains respec-
tively (-0.48 and -0.54).
Known-groups validity
The differences in the WOMAC pain and function short
mean scales were significant among the three severity
groups according to the pain and function categorical
scales (Table 4). Patients with a higher level of severity
had significantly (P< 0.0001) higher scores on the
WOMAC pain or function short scale.
Responsiveness
There were no significant differences among the partici-
pants who responded to the follow-up and those who
did not. Both the WOMAC pain and function short
scales showed minor floor and ceiling effects (< 2%)
before the intervention (Table 5). After the intervention,
the WOMAC pain and function short scales increased
39.28 and 39.99 points, respectively, both of which were
significant (P< 0.0001). The SES and SRM responsive-
ness parameters were much higher than 0.80 in both
pain and function short scales, indicating large changes
(Table 5).
Agreement between the long and short womac forms
The long and short WOMAC scales at baseline, 6
months after the intervention, and the change scores
were highly correlated (pain, r = 0.94, 0.97, and 0.94,
respectively; and function, r = 0.95, 0.98, and 0.96,
respectively). Agreement between the WOMAC long
and short scales evaluated by the Bland-Altman
approach is shown in Figure 1 and 2. For both domains,
more than 95% of the differences between the two scales
can be expected to be within the limits of agreement,
and the variability was random and uniform along the
range of values.
Discussion
The results of the current prospective study with two
independent and large cohorts of patients who under-
went THR at different hospitals and who were followed
to 6 months support the validity, reliability, and respon-
siveness of the new 11-item version of the WOMAC.
To the best of our knowledge, this is the first study to
validate a shortened WOMAC version as a whole tool,
including both pain and function dimensions, and most
importantly, the first valid, reliable, and responsive
WOMAC short version proposed in Spanish.
The WOMAC questionnaire is widely used both in
research studies in orthopedic or rheumatologic pro-
cesses as in clinical practice [1-5,7]. One of the major
disadvantages of self-administered questionnaires has
been the burden of its completion [41]. In some epide-
miological and clinical studies, patients usually have to
complete several questionnaires implying a great burden.
In clinical practice, where information is collected to
evaluate response to treatment, the goal is to involve as
little effort as possible for both the patient and the phy-
sician. Therefore, if using a shortened version the same
information is collected but with little burden, the
instrument would be useful. In addition, another disad-
vantage of self-administered questionnaires has been the
Table 2 Results of factor loading and fit indexes of
Confirmatory Factor Analysis of the WOMAC short
questionnaire in both cohorts
Items* Item description Cohort 1
(n = 788)
Cohort 2
(n = 445)
Pain Function Pain Function
Pain item 1 Walking on flat
surface
0.75 - 0.77 -
Pain item 2 Up/down stairs 0.84 - 0.84 -
Pain item 4 Sitting or lying 0.53 - 0.59 -
Function item
1
Descending stairs - 0.74 - 0.74
Function item
2
Ascending stairs - 0.74 - 0.77
Function item
3
Rising from sitting - 0.67 - 0.67
Function item
6
Walking on flat
surface
- 0.69 - 0.72
Function item
7
Getting in/out of a
car
- 0.67 - 0.71
Function item
8
Shopping - 0.71 - 0.70
Function item
9
Putting on socks - 0.55 - 0.53
Function item
15
Getting on/off toilet - 0.66 - 0.67
c
2 (df) 226.11 (40) 119.97 (40)
RMSEA 0.0792 0.0690
CFI 0.9539 0.9650
NNFI 0.9366 0.9518
*Items are referred to by the original name in the WOMAC long form.
df = degrees of freedom; RMSEA = root mean square error of approximation;
CFI = comparative fit index; NNFI = non-normed fit index.
Correlation between the two latent factors (pain and function) is set to be
different from 0, therefore both latent factors are specified to be
intercorrelated. The estimation of the correlation coefficient was 0.89 in the
first cohort and 0.82 in the second one.
Covariance was specified between the error items of the following three pair
of items: “Pain walking on flat surface” and “functional limitation walking on
flat surface”, “pain up/down stairs” and “functional limitation ascending stairs”,
and “functional limitation getting in/out of a car” and “functional limitation
putting on socks”.
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ity [15,16]. Patients missing items has important impli-
cations for data collection, completion, and analysis.
However, it has been shown that shorter version of the
questionnaires would significantly increase the response
rate [15], and the compliance increased when the
respondent was asked to complete an appreciably smal-
ler set of questions [42]. Therefore, a shorter version
would further enhance its applicability in epidemiologic
studies, and daily clinical practice [13]. On the other
hand, a consequence of the reduction of items is a loss
in content validity, the comprehensiveness with which
each domain is sampled, and investigators must be cog-
nizant of this issue when they reduce the number of
items [12]. Because of a greater length of the question-
naire, it provides a detailed insight of different dimen-
sions. However, this might also be a disadvantage,
because of reduced patient compliance and incomplete
response [14]. Therefore, it would be very useful to have
a shortened WOMAC version in Spanish, which retains
the same good psychometric properties of its original
version.
The aim of the current study was to propose a new
short WOMAC form and validate it in Spanish. Fair-
clough [43] commented that it is preferable to select a
previously validated instrument than to create a new
one. Considering this, and according to the different
short versions of the WOMAC pain domain proposed
by other investigators [19,20], we selected the shortened
pain scale proposed by Davis et al [19]. They shortened
the WOMAC pain domain using Rasch analysis in a
community sample of 773 patients with a hip or knee
complaint. The authors concluded that the pain short
scale fits the Rasch model and has interval-level scaling
properties, and the stability of the model also was sup-
ported by a sample of 1,151 surgical patients. Rothen-
fluh et al. [20] proposed a different three-item pain
short version that had two items in common with the
version proposed by Davis et al. [19], but the authors
based it on a very small sample of patients with hip OA
(n = 57). Taking into account our objectives, the metho-
dology used by Davis et al. [19] for the reduction study,
the larger sample size, and that both shortened pain
domains had the same number of items, we decided
that the pain short form proposed by Davis et al. [19]
was more adequate.
Regarding the WOMAC function short forms, other
versions have been proposed by different authors
[11,19-21]. Davis et al. [19], who based their new version
on the Rasch model, also proposed a shortened version
of the function scale. Nevertheless, they only excluded
three items from the original version, and we did not
consider short enough. Rothenfluh et al. [20] also pro-
posed a nine-item short version of the function scale
Table 3 Severity levels, standard errors, and goodness of fit indices of the pain and function short scales with
application of the Rasch model in both cohorts
Items* Item description Cohort 1
(n = 788)
Cohort 2
(n = 445)
δ
(logit)
SE Infit
MNSQ
Outfit
MNSQ
Rank based on
logit
δ
(logit)
SE Infit
MNSQ
Outfit
MNSQ
Rank based on
logit
Pain
†
Item 4 Sitting or lying 2.21 0.07 1.33 1.32 1 2.30 0.09 1.30 1.29 1
Item 1 Walking on flat
surface
-0.15 0.07 0.76 0.75 2 -0.07 0.09 0.84 0.87 2
Item 2 Up/down stairs -2.06 0.07 0.88 0.89 3 -2.23 0.09 0.79 0.79 3
Function
‡
Item 6 Walking on flat
surface
1.42 0.05 0.88 0.89 1 1.34 0.07 0.87 0.87 1
Item
15
Getting on/off
toilet
0.83 0.05 1.15 1.14 2 0.96 0.07 1.16 1.15 2
Item 1 Descending stairs 0.63 0.05 1.01 0.99 3 0.37 0.07 1.00 0.97 3
Item 8 Shopping 0.01 0.06 1.07 1.04 4 0.01 0.08 1.08 1.04 4
Item 3 Rising from sitting -0.15 0.06 0.93 0.95 5 -0.01 0.08 0.96 1.00 5
Item 2 Ascending stairs -0.25 0.06 0.86 0.85 6 -0.36 0.08 0.84 0.79 6
Item 7 Getting in/out of
car
-0.96 0.06 0.84 0.81 7 -0.91 0.08 0.85 0.82 7
Item 9 Putting on socks -1.53 0.06 1.30 1.17 8 -1.41 0.09 1.32 1.22 8
*Items are referred to by the original name in the WOMAC long form.
†Cohort 1: person separation index = 1.55; item separation index = 24.98; cohort 2: person separation index = 1.56; item separation index = 19.44.
‡Cohort 1: person separation index = 2.25; item separation index = 15.39; cohort 2: person separation index = 2.21; item separation index = 10.44.
δ = level of severity (higher values indicate higher severity); SE = standard error; MNSQ = mean square fit statistic.
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of patients with hip OA (n = 57). Given that our target
population is composed of patients with hip OA, we did
not consider large enough the sample they used. White-
house et al. [21] reduced the 17-item function scale to
seven items by a clinically driven process based on the
opinions of 36 orthopaedic and rheumatology personnel.
The authors studied the validity, reliability, and respon-
siveness of the short scale in patients with hip or knee
OA [21], and the criterion validity and repeatability of
this reduced function scale also was assessed in a sample
of 100 patients, but only 30 had THR [42]. This short
function scale also was validated in an independent
cohort, but using a sample of patients with knee OA [14].
Finally, Tubach et al. [11], reduced the function scale
from 17 items to eight, based on the opinions of 1,362
patients with hip or knee OA and 399 rheumatologists.
This short function scale was validated in an independent
sample of patients with hip or knee OA, and it was found
to be responsive, reproducible, and valid [25]. Although
Whitehouse et al. [21] and Tubach et al. [11] used similar
methods for shortening the scales, the latter considered
more expert opinions, added patient opinions, and the
scale was validated by also considering patients with hip
OA. Therefore, we selected the function short scale pro-
posed by Tubach et al. [11].
The validation studies of the various shortened
WOMAC versions [11,14,19-21,25,42] have consisted of
studying the measurement properties of the correspond-
ing shortened WOMAC pain or function scales indivi-
dually. In our study, we validated our new 11-item
WOMAC-SF as an entire tool, including both pain and
function dimensions, and studying the construct validity
of the short version to test the hypothesis that the 11
items in the questionnaire comprised two separate fac-
tors. Validation of the 11-item WOMAC-SF using CFA
provides the questionnaire with greater construct valid-
ity. The CFA results confirmed the hypothesized inter-
nal structure of the two latent factors, given that all fit
indices were satisfactory and all factor weights exceeded
the recommended thresholds [26-29]. We also con-
firmed the internal structure of the 11-item WOMAC-
SF by CFA performed in an independent cohort. A
Table 4 Correlation between the WOMAC short scales
and SF-36 domains, and known-groups validity of the
WOMAC short scales in cohort 1 (n = 788)
WOMAC short scales
SF-36 domains Pain
r coefficient
Function
r coefficient
Physical functioning -0.44 -0.54
Role physical -0.34 -0.36
Bodily pain -0.48 -0.50
General health -0.19 -0.17
Vitality -0.32 -0.33
Social functioning -0.38 -0.38
Role emotional -0.17 -0.13
Mental health -0.29 -0.25
Summary physical component -0.34 -0.41
Summary mental component -0.28 -0.25
Pain
Mean(SD)
Function
Mean(SD)
Pain categorical scale
Minor (n = 32)
a 24.74 (12.96)
b, c 46.23 (17.56)
b, c
Moderate (n = 171)
b 43.68 (14.16)
a, c 57.97 (16.93)
a, c
Severe (n = 579)
c 61 (17.16)
a, b 72.67 (14.99)
a, b
P value < 0.0001 < 0.0001
Functional limitation categorical scale
Minor (n = 79)
a 43.38 (16.63)
b, c 54.06 (17.48)
b, c
Moderate (n = 422)
b 51.70 (17.53)
a, c 65.38 (15.70)
a, c
Severe (n = 286)
c 64.94 (17.56)
a, b 76.68 (15.43)
a, b
P value < 0.0001 < 0.0001
r: Spearman correlation coefficient.
Data are expressed as the Spearman correlation coefficient when studying the
correlation between the WOMAC short scales and the SF-36 domains, and as
the mean (SD) when comparing the WOMAC short scales according to the
pain and functional limitation short categorical scales.
The scores for the WOMAC domains range from 0 to 100, with higher scores
indicating worse health status. The scores for the SF-36 domains range from 0
to 100, with higher scores indicating better health status.
abc Superscript letters indicated differences among the three subgroups by
Scheffe’s test for multiple comparisons at P< 0.05.
Table 5 Responsiveness parameters 6 months after
intervention in the WOMAC short scales in cohort 1
(n = 590)
Parameters WOMAC short scales
Pain Function
% at floor
Preintervention 0.68 0.17
Postintervention 31.21 6.24
% at ceiling
Preintervention 1.88 1.89
Postintervention 0.17 0.17
Mean (SD)
Preintervention 55.69 (18.64) 67.88 (17.44)
Postintervention 16.36 (17.95) 27.74 (19.48)
Change 39.28 (23.14) 39.99 (23.14)
P value* < 0.0001 < 0.0001
SES 2.11 2.29
SRM 1.70 1.73
*Paired t-test to compare the mean preintervention and postintervention
scores.
% at floor = percentage of the study population at the lowest possible scale
level; % at ceiling = percentage of the study population at the highest
possible scale level; SD = Standard deviation; SES = Standardised effect size;
SRM = Standardised response mean.
The scores for the WOMAC domains range from 0 to 100, with higher scores
indicating worse health status.
Changes were calculated by subtracting postintervention scores from
preintervention scores; a positive result indicates a gain.
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distribution of items when using the CFA. However, it
has been argued that the maximum likelihood estima-
tion procedure appear to be fairly robust against moder-
ate violation of this assumption [29]. In addition, some
studies, based upon experience or computer simulations,
have claimed that scales with as few as five points yield
stable factors [37]. Therefore, taking into account that
we use a 5-points Likert scale, a maximum likelihood
estimator procedure, and that we have a large sample
Figure 1 The Bland-Altman plot shows the difference in the WOMAC long and short pain scales plotted against the mean value of
these two scales. The three horizontal lines indicate the mean individual differences d ± 1.96 SD (limits of agreement). The mean (SD) of the
WOMAC long and short pain scales at baseline were 54.27 (18.63) and 55.70 (18.93), respectively. The mean (SD) of the difference between both
scales was -1.47 (6.15). Limit of agreement: -13.52 to 10.58.
Figure 2 The Bland-Altman plot shows the difference in the WOMAC long and short function scales plotted against the mean value of
these two scales. The three horizontal lines indicate the mean individual differences d ± 1.96 SD (limits of agreement). The mean (SD) of the
WOMAC long and short function scales at baseline were 65.19 (16.61) and 68.36 (17.29), respectively. The mean (SD) of the difference between
both scales was -3.15 (4.90). Limit of agreement: -12.75 to 6.45.
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think that our CFA results are reliable and stable.
The Rasch method applied to the three-item pain
short domain and the eight-item function short domain
provided adjustment levels (infit and outfit) and unidi-
mensionality sufficient to be considered adequate, pro-
viding major evidence of construct validity. Although
two of the items, the item “pain on sitting or lying” rela-
tive to pain scale and the item “putting on socks” rela-
tive to function scale, presented infit or outfit statistics
slightly above the recommended threshold of 1.3, taking
into account the satisfactory results obtained from the
rest of analysis, such as PCA of the residuals, the func-
tioning of the rating scale categories, the absence of DIF
by gender in both items, and the item and person
separation indexes, we do not consider that the slight
difference in these infit or outfit indexes with respect to
the recommended limit 1.3 is large enough to conclude
that these two items are misfitting items. Regarding the
three-item pain short form, the results were similar to
those reported by Davis et al [19]. Considering that the
criteria were satisfactory, we concluded that the shor-
tened WOMAC pain scale fit the Rasch model. Regard-
ing the eight-item function short form, we obtained a
scale that shows the fundamental properties of model fit
and unidimensionality.
Analysis of the internal consistency allowed us to con-
firm the hypothesis that the items that comprised the
pain short scale or those that comprised the function
short scale measured the same concept as Cronbach’s
alpha coefficient exceeded the threshold of 0.70 [36].
For the function short scale, the results were similar to
or slightly higher than those reported by the original
authors of the short form [11,25]. Further, the reliability
of the 11-item WOMAC-SF, although it was as high as
that for the original Spanish WOMAC questionnaire
(0.82 for pain domain and 0.93 for function domain)
because of the reduction of the number of items, it was
slightly lower, indicating that it maintained excellent
internal consistency [8].
The convergent and discriminant validity of the
WOMAC-SF was assessed by examining the relationship
between the pain and function short scales and the fac-
tors of the SF-36. Validity was demonstrated by correla-
tion coefficients lower than the internal consistency of
the short forms and by confirming the hypothesis that
the highest correlation coefficients were found between
the WOMAC pain short form and the SF-36 bodily pain
domain and between the WOMAC function short form
and the physical function domain of the SF-36. Baron et
al. [25] also reported satisfactory convergent validity of
the eight-item function WOMAC short form, but they
used measures other than the SF-36. Whitehouse et al.
[21] studied the convergent validity of their proposed
seven-item function short form using the SF-36 physical
function domain, and although the results were similar
to those we obtained, in our case the correlation coeffi-
cient was slightly higher. Further, we obtained similar
results to those of the original WOMAC questionnaire
[8], since they also found the highest correlation coeffi-
cient between the WOMAC pain and function long
scales and the SF-36 bodily pain and physical function-
ing domains (-0.55 and -0.59, respectively). Otherwise,
the WOMAC-SF maintained excellent known-groups
validity similar to that of the original WOMAC ques-
tionnaire [8], since they also observed that the more
severity level, the higher their WOMAC pain and func-
tion long scores were.
The 11-item WOMAC-SF showed good responsive-
ness 6 months after the intervention. Responsiveness
parameters were substantially above the 0.80 threshold
for designating large change [39]. Tubach et al. [11] and
Baron et al. [25] also reported this finding for the func-
tion short form, although we found much higher
responsiveness parameters, probably due to the follow-
up period. We considered a follow-up of 6 months,
whereas they considered 4 weeks. Whitehouse et al.
[21], who purposed a seven-item function WOMAC-SF,
studied the responsiveness considering follow-up periods
of 3 months and 1 year, and Auw Yang et al. [14], who
validated the previous seven-item function WOMAC-SF
in a different cohort, also studied the responsiveness
considering follow-up periods of 3 and 6 months.
Nevertheless, the responsiveness parameters of the
seven-item function WOMAC-SF that they reported
[14,21] were much lower than our responsiveness para-
meters of the eight-item function short form that we
proposed, indicating that the eight-item function short
form is more responsive than the seven-item function
short form proposed by Whitehouse et al. [21]. Further,
the responsiveness results of the 11-item WOMAC-SF
we obtained were similar to those of the original
WOMAC questionnaire [9], given that they also found
minor floor and ceiling effects (< 2%) before the inter-
vention, and the SES and SRM responsiveness para-
meters were practically equal (2.10 and 1.86 respectively
for pain domain, and 2.34 and 1.80 respectively for
function domain).
The strong correlation between the long and short
WOMAC pain or function scales and the high agree-
ment in scores examined by the Bland-Altman approach
[40] support the hypothesis that the shortened scale
captures pain and functional status as well as the origi-
nal WOMAC version. Our results are similar to those
found by Tubach et al. [11] and Baron et al. [25].
A possible limitation of the current study was the use
of the data provided by the original WOMAC long form
to validate the 11-item WOMAC-SF [25]. This might
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the similarity between the two forms [21,25]. Although
this problem is inherent in many validation studies
[11,25], in the current study, whenever possible, we ana-
lyzed separate samples to compensate for this problem
as much as possible. Nevertheless, the 11-item
WOMAC-SF must be validated in a new independent
sample of patients with hip OA and in different lan-
guages. Besides, the original WOMAC has been used in
patients with hip or knee OA, consequently this 11-
items short form could probably be applicable in both
patients with hip or knee OA. However, we have based
our study only on patients undergoing total hip replace-
ment, and therefore, further validation studies in
patients with different arthroplasties would be necessary
to be completely sure about the applicability of this
short WOMAC form.
In addition, an instrument must be reliable, valid, and
responsive to be useful. Although we studied the relia-
bility of the 11-item WOMAC-SF by means of the
Cronbach alpha coefficient to measure the internal con-
sistency, the reliability study should be complemented
with a test-retest study. Regarding responsiveness, miss-
ing data are a key limitation of the prospective cohort
design and a usual finding when conducting follow-up
studies [11,21,25]. In our case, there was a very good
response rate before the intervention (about 80%) in
both cohorts, and 6 months aft e ri t( a b o u t7 5 % ) .T h e s e
losses occurred despite our mailing up to two reminders
and contacting nonresponders by telephone. However,
no differences were observed in relevant variables when
responders were compared with nonresponders. There-
fore, although a bias may have been present in our
responsiveness study due to missing data, it is likely to
be minor and we believe the results are generalizable to
the entire sample.
Conclusions
In conclusion, we proposed an 11-item WOMAC-SF,
based on previous studies, for patients with hip OA
undergoing THR. This complete validation process,
which used two independent and large patient samples
and combined classical and contemporary methods,
such as Rasch analysis, showed that the 11-item Spanish
WOMAC-SF is valid, reliable, and responsive for mea-
suring pain and function in patients with hip OA under-
going THR, and most importantly, the first WOMAC
short version proposed in Spanish. Its simplicity and
easy of application will increase its acceptability and
usefulness within the orthopaedic community, and,
therefore, it may be of interest in routine practice given
that the goal is to collect information involving as little
effort as possible for both the patient and the physician.
In clinical research, where patients usually have to
complete several questionnaires implying a great burden,
short questionnaires result in improved patient compli-
ance and response rates, therefore this shorter version
will further enhance its applicability. In conclusion, this
short version is a good alternative to the original
WOMAC questionnaire, since the 11-item WOMAC-SF
retains properties of the original WOMAC version.
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